News
A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...
During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...
After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
Proton therapy is an advanced radiation treatment that precisely targets tumors with a goal of limiting harm to healthy tissue. It may help reduce short- and long-term side effects, lower the risk of ...
There's a growing interest in the use of bone-modifying agents, or BMAs, known as bisphosphonates in the cancer patient population. But these agents can cause short- and long-term side effects. What’s ...
A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.
There is much to consider when it comes to using the new semaglutide drugs for weight loss, especially for cancer patients. Fred Hutch experts weight in.
Far too many cancer patients face barriers to participating in clinical trials due to overly restrictive trial criteria. Here's how Fred Hutch researchers are changing that..
Results that may be inaccessible to you are currently showing.
Hide inaccessible results